Stem Cells and Resynchronization Cardiac
Sponsor:
Instituto de Molestias Cardiovasculares
Country:
Brazil About 120cc of blood is collected from the iliac bone marrow. In the lab this blood is harvested and mononuclear cells are separated. This procedure takes about4 hours. After dilution, the mononuclear cells are injected into the cardiac muscles with fibroses area through 20 shots. This procedure is indicated for patients with cardiac ischemia and left ventricular dysfunction(desynchrony), on whom all the others known therapies have not succeeded.
Eligible Ages for Trial:
18-75
Eligible Genders for Trial:
Both
Illness:
Heart Disease Criteria
- Heart Failure
- Dilated Cardiomyopathy
- Optimized Therapeutics
- Functional Class III or IV
- Ventricular Desynchrony
- Ejection Fraction(Echo/ Sympson) < 35%
November 1, 2008 - November 1, 2009
Trial Status:
Recruiting Contact:
Oswaldo Tadeu Greco, PhD 55-17-3203-4000 ext 4038 oswaldogreco@terra.com.br

